Baxter International Inc.’s acquisition of Gambro AB is complete
This transaction unites two companies with strong histories of product innovation and a shared commitment to advancing therapeutic options for dialysis and intensive care patients globally.
Applying our combined expertise and expanded product portfolio helps address the distinct needs of patients and customers in the chronic and acute care therapeutic areas.
The completion of the acquisition marks the beginning for the integration of Baxter and Gambro. We are committed to seamlessly integrating the businesses and continuing to provide you with the highest level of service, s...